Akira Kawamura to Aged
This is a "connection" page, showing publications Akira Kawamura has written about Aged.
Connection Strength
0.596
-
Kariya M, Yamamoto K, Kawamura A, Tanizaki S, Ueda K, Sai K, Hata A. Cystine and theanine for chemoradiotherapy-induced esophagitis in non-small cell lung cancer: a prospective observational study. Support Care Cancer. 2024 Jun 03; 32(6):400.
Score: 0.026
-
Kawamura A, Miura S, Murayama T, Iwata A, Zhang B, Nishikawa H, Tsuchiya Y, Matsuo K, Tsuji E, Saku K. Increased expression of monocyte CD11a and intracellular adhesion molecule-1 in patients with initial atherosclerotic coronary stenosis. Circ J. 2004 Jan; 68(1):6-10.
Score: 0.026
-
Kawamura A, Miura S, Murayama T, Iwata A, Nishikawa H, Matsuo Y, Tsuchiya Y, Matsuo K, Tsuji E, Saku K. Changes in the expression of leukocyte adhesion molecules throughout the acute phase of myocardial infarction. J Atheroscler Thromb. 2004; 11(1):29-34.
Score: 0.026
-
Kawamura A, Miura S, Fujino M, Nishikawa H, Matsuo Y, Tanigawa H, Tomita S, Tsuchiya Y, Matsuo K, Saku K. CXCR3 chemokine receptor-plasma IP10 interaction in patients with coronary artery disease. Circ J. 2003 Oct; 67(10):851-4.
Score: 0.025
-
Kawamura A, Adachi K, Takashima T, Fujishiro H, Yuki M, Ishihara S, Kinoshita Y. Helicobacter pylori-independent effect of hyperglycemia on gastric mucosal atrophy. Am J Gastroenterol. 2002 Sep; 97(9):2479-80.
Score: 0.023
-
Nakamura M, Ike A, Kato Y, Futami M, Kuwano T, Sugihara M, Iwata A, Kawamura A, Suematsu Y, Miura SI. Differences in lesion characteristics and patient background associated with the medium-term clinical outcomes of bare-metal and first-, second- and third-generation drug-eluting stents. Heart Vessels. 2021 Feb; 36(2):211-222.
Score: 0.020
-
Kawamura A, Sekine T, Sekiguchi M, Yanoma S, Kaneko A, Haneda T, Moriya Y, Hayasaka K, Kakizoe T. Six-year disease-free survival of a patient with metastatic eyelid squamous cell carcinoma and colon adenocarcinoma after repeated postoperative adoptive immunotherapy. Jpn J Clin Oncol. 2000 Jun; 30(6):267-71.
Score: 0.020
-
Kaneko S, Noguchi H, Fu R, Kang C, Kawamura A, Amano S, Miyawaki A. Differences in cancer patients' work-cessation risk, based on gender and type of job: Examination of middle-aged and older adults in super-aged Japan. PLoS One. 2020; 15(1):e0227792.
Score: 0.019
-
Fu R, Noguchi H, Kaneko S, Kawamura A, Kang C, Takahashi H, Tamiya N. How do cardiovascular diseases harm labor force participation? Evidence of nationally representative survey data from Japan, a super-aged society. PLoS One. 2019; 14(7):e0219149.
Score: 0.019
-
Moriyama Y, Tamiya N, Kawamura A, Mayers TD, Noguchi H, Takahashi H. Effect of short-stay service use on stay-at-home duration for elderly with certified care needs: Analysis of long-term care insurance claims data in Japan. PLoS One. 2018; 13(8):e0203112.
Score: 0.018
-
Jin X, Tamiya N, Jeon B, Kawamura A, Takahashi H, Noguchi H. Resident and facility characteristics associated with care-need level deterioration in long-term care welfare facilities in Japan. Geriatr Gerontol Int. 2018 May; 18(5):758-766.
Score: 0.017
-
Koyoshi R, Hitaka-Yoshimine Y, Shiga Y, Kuwano T, Sugihara M, Ike A, Iwata A, Sako H, Morito N, Kawamura A, Miura SI. Associations between microalbuminuria and parameters of flow-mediated vasodilatation obtained by continuous measurement approaches. Clin Exp Hypertens. 2018; 40(8):715-720.
Score: 0.017
-
Matsuoka Y, Ike A, Ogawa M, Gondo K, Shirai K, Sugihara M, Nose D, Nishikawa H, Iwata A, Kawamura A, Mori K, Zhang B, Yasunaga S, Miura SI, Saku K. Sex difference between target levels of cholesterol-related parameters and post-PCI long-term clinical outcomes: From the FU-Registry. J Cardiol. 2018 03; 71(3):259-267.
Score: 0.017
-
Fu R, Noguchi H, Kawamura A, Takahashi H, Tamiya N. Spillover effect of Japanese long-term care insurance as an employment promotion policy for family caregivers. J Health Econ. 2017 12; 56:103-112.
Score: 0.017
-
Shiiba M, Zhang B, Miura SI, Ike A, Nose D, Kuwano T, Imaizumi S, Sugihara M, Iwata A, Nishikawa H, Kawamura A, Shirai K, Yasunaga S, Saku K. Association between discordance of LDL-C and non-HDL-C and clinical outcomes in patients with stent implantation: from the FU-Registry. Heart Vessels. 2018 Feb; 33(2):102-112.
Score: 0.016
-
Gondo K, Ike A, Ogawa M, Shirai K, Sugihara M, Nishikawa H, Iwata A, Kawamura A, Mori K, Zhang B, Miura S, Yasunaga S, Saku K. Is a bare-metal stent still useful for improving the outcome of percutaneous coronary intervention? From the FU-Registry. J Cardiol. 2017 04; 69(4):652-659.
Score: 0.015
-
Ike A, Shirai K, Nishikawa H, Iwata A, Yahiro E, Sugihara M, Kawamura A, Uehara Y, Zhang B, Ogawa M, Mori K, Miura S, Saku K. Associations between different types of hypoglycemic agents and the clinical outcome of percutaneous coronary intervention in diabetic patients-From the FU-Registry. J Cardiol. 2015 May; 65(5):390-6.
Score: 0.013
-
Nagata I, Ike A, Nishikawa H, Zhang B, Sugihara M, Mori K, Iwata A, Kawamura A, Shirai K, Uehara Y, Ogawa M, Miura S, Saku K. Associations between lipid profiles and MACE in hemodialysis patients with percutaneous coronary intervention: from the FU-Registry. J Cardiol. 2015 Feb; 65(2):105-11.
Score: 0.013
-
Morii J, Miura S, Ike A, Shiga Y, Sugihara M, Iwata A, Kawamura A, Nishikawa H, Saku K. Comparison of the efficacies of irbesartan and olmesartan after successful coronary stent implantation. Intern Med. 2013; 52(7):713-9.
Score: 0.012
-
Sugihara M, Miura S, Nishikawa H, Ike A, Mori K, Iwata A, Kawamura A, Saku K. Characteristics of patients and types of lesions in patients with drug-eluting or bare-metal stent implantation in small coronary arteries: from the FU-Registry. J Cardiol. 2013 Feb; 61(2):117-21.
Score: 0.012
-
Iwata A, Miura S, Tanaka T, Ike A, Sugihara M, Nishikawa H, Kawamura A, Saku K. Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin. Coron Artery Dis. 2012 Aug; 23(5):315-21.
Score: 0.012
-
Arimura T, Miura S, Ike A, Sugihara M, Iwata A, Nishikawa H, Kawamura A, Saku K. Comparison of the efficacy and safety of statin and statin/ezetimibe therapy after coronary stent implantation in patients with stable angina. J Cardiol. 2012 Aug; 60(2):111-8.
Score: 0.011
-
Mito T, Miura S, Iwata A, Morii J, Sugihara M, Ike A, Mori K, Kawamura A, Nishikawa H, Zhang B, Saku K. Determination of the cut-off plasma adiponectin level associated with a lower risk of restenosis in patients with stable angina. Coron Artery Dis. 2011 Nov; 22(7):451-7.
Score: 0.011
-
Kuwano T, Miura S, Shirai K, Ike A, Mori K, Shimizu T, Zhang B, Iwata A, Nishikawa H, Kawamura A, Saku K. Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis: a new look at an old molecule. J Atheroscler Thromb. 2011; 18(7):574-83.
Score: 0.011
-
Takamiya Y, Miura S, Tsuchiya Y, Fukuda Y, Zhang B, Kuwano T, Ike A, Yanagi D, Kubota K, Mori K, Iwata A, Nishikawa H, Kawamura A, Miller N, Matsuo K, Shirai K, Saku K. Angiographic late lumen loss at the site of overlap of multiple Cypher? sirolimus-eluting stents: ALSOCE study. J Cardiol. 2011 Mar; 57(2):187-93.
Score: 0.010
-
Fukuda Y, Miura S, Zhang B, Iwata A, Kawamura A, Nishikawa H, Shirai K, Saku K. Significance of urinary liver-fatty acid-binding protein in cardiac catheterization in patients with coronary artery disease. Intern Med. 2009; 48(19):1731-7.
Score: 0.010
-
Takamiya Y, Miura S, Kawamura A, Tanigawa H, Zhang B, Iwata A, Nishikawa H, Matsuo K, Shirai K, Saku K. Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease. Coron Artery Dis. 2009 Jun; 20(4):288-94.
Score: 0.009
-
Sugihara M, Miura S, Takamiya Y, Kiya Y, Arimura T, Iwata A, Kawamura A, Nishikawa H, Uehara Y, Saku K. Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation. Hypertens Res. 2009 Jul; 32(7):625-30.
Score: 0.009
-
Mitsutake R, Miura S, Kawamura A, Saku K. Are metabolic factors associated with coronary artery stenosis on MDCT? Circ J. 2009 Jan; 73(1):132-8.
Score: 0.009
-
Mitsutake R, Miura S, Shiga Y, Kawamura A, Saku K. Is chronic kidney disease associated with coronary artery stenosis or calcification as assessed by multi-detector row computed tomography? Intern Med. 2008; 47(21):1835-41.
Score: 0.009
-
Kimura K, Miura S, Iwata A, Sugihara M, Arimura T, Nishikawa H, Kawamura A, Saku K. Association between cardiac function and metabolic factors including adiponectin in patients with acute myocardial infarction. J Cardiol. 2009 Feb; 53(1):65-71.
Score: 0.009
-
Iwata A, Miura S, Mori K, Kawamura A, Nishikawa H, Saku K. Associations between metabolic factors and coronary plaque growth or arterial remodeling as assessed by intravascular ultrasound in patients with stable angina. Hypertens Res. 2008 Oct; 31(10):1879-86.
Score: 0.009
-
Kawamura A, Tanaka H. Rickettsiosis in Japan. Jpn J Exp Med. 1988 Aug; 58(4):169-84.
Score: 0.009
-
Yanagi D, Shirai K, Takamiya Y, Fukuda Y, Kuwano T, Ike A, Mori K, Kubota K, Iwata A, Fujimi K, Kawamura A, Nishikawa H, Miller N, Zhang B, Tsuchiya Y, Urata H, Saku K. Results of provisional stenting with a Sirolimus-eluting stent for bifurcation lesion: multicenter study in Japan. J Cardiol. 2008 Apr; 51(2):89-94.
Score: 0.009
-
Sako H, Miura S, Iwata A, Nishikawa H, Kawamura A, Matsuo K, Shirai K, Saku K. Changes in CCR2 chemokine receptor expression and plasma MCP-1 concentration after the implantation of bare metal stents versus sirolimus-eluting stents in patients with stable angina. Intern Med. 2008; 47(1):7-13.
Score: 0.008
-
Mitsutake R, Niimura H, Miura S, Zhang B, Iwata A, Nishikawa H, Kawamura A, Kumagai K, Shirai K, Matsunaga A, Saku K. Clinical significance of the coronary calcification score by multidetector row computed tomography for the evaluation of coronary stenosis in Japanese patients. Circ J. 2006 Sep; 70(9):1122-7.
Score: 0.008
-
Iwata A, Miura S, Shirai K, Kawamura A, Tomita S, Matsuo Y, Zhang B, Nishikawa H, Kumagai K, Matsuo K, Saku K. Lower level of low-density lipoprotein cholesterol by statin prevents progression of coronary restenosis after successful stenting in acute myocardial infarction. Intern Med. 2006; 45(15):885-90.
Score: 0.008
-
Imaizumi S, Miura S, Nishikawa H, Iwata A, Zhang B, Kawamura A, Tsuchiya Y, Kumagai K, Matsuo K, Saku K. Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease. Hypertens Res. 2006 Mar; 29(3):135-41.
Score: 0.007
-
Iwata A, Miura S, Nishikawa H, Kawamura A, Matsuo Y, Sako H, Kumagai K, Matsuo K, Saku K. Significance of combined angiotensin II receptor blocker and carvedilol therapy in patients with congestive heart failure and arginine variant. J Cardiol. 2006 Jan; 47(1):1-7.
Score: 0.007
-
Nishikawa H, Miura S, Shimomura H, Kawamura A, Tsujita K, Shirai K, Matsuo K, Arai H, Saku K. Effect of statin on restenosis after radius stent implantation in patients with acute coronary syndrome. J Atheroscler Thromb. 2005; 12(6):302-6.
Score: 0.007
-
Adachi K, Arima N, Takashima T, Miyaoka Y, Yuki M, Ono M, Komazawa Y, Kawamura A, Fujishiro H, Ishihara S, Kinoshita Y. Pulse-wave velocity and cardiovascular risk factors in subjects with Helicobacter pylori infection. J Gastroenterol Hepatol. 2003 Jul; 18(7):771-7.
Score: 0.006
-
Miura S, Nishikawa H, Zhang B, Matsuo Y, Kawamura A, Tsuchiya Y, Matsuo K, Saku K. Angiotensin-converting enzyme inhibitor promotes coronary collateral circulation in patients with coronary artery disease. Circ J. 2003 Jun; 67(6):535-8.
Score: 0.006
-
Takashima T, Adachi K, Kawamura A, Yuki M, Fujishiro H, Rumi MA, Ishihara S, Watanabe M, Kinoshita Y. Cardiovascular risk factors in subjects with Helicobacter pylori infection. Helicobacter. 2002 Apr; 7(2):86-90.
Score: 0.006
-
Adachi K, Kawamura A, Ono M, Masuzaki K, Takashima T, Yuki M, Fujishiro H, Ishihara S, Kinoshita Y. Comparative evaluation of urine-based and other minimally invasive methods for the diagnosis of Helicobacter pylori infection. J Gastroenterol. 2002; 37(9):703-8.
Score: 0.006
-
Miyairi T, Kijima H, Murata M, Nogami S, Shirasaka A, Tanaka H, Kawamura A. [Shichito fever in Izu Shichito Islands. 4. Incidence of anti-R. tsutsugamushi antibody among inhabitant's sera (author's transl)]. Kansenshogaku Zasshi. 1980 Jun; 54(6):284-90.
Score: 0.005
-
Kawamura A, Murata M, Osono M, Nogami S, Shirasaka A, Tanaka H, Sudo K, Suzuki K, Miyairi T, Kijima H. Studies on inapparent infection of tsutsugamuschi disease in Izu Shichito Islands: seroepidemiology and demonstration of an avirulent Rickettsia strain for mice. Jpn J Exp Med. 1980 Apr; 50(2):91-105.
Score: 0.005
-
Lynn T, Tu S, Hirayama T, Kawamura A. Nasopharyngeal carcinoma and Epstein-Barr virus. I. Factors related to the anti-VCA antibody. Jpn J Exp Med. 1973 Apr; 43(2):121-33.
Score: 0.003
-
Kawamura A, Takada M, Goto A, Hamajima K, Sanpe T. Seroepidemiological studies on nasopharyngeal carcinoma by fluorescent antibody techniques with cultured Burkitt lymphoma cell. Gan. 1970 Feb; 61(1):55-71.
Score: 0.002
-
Murata M, Nogami S, Shirasaka A, Tanaka H, Kawamura A, Mochizuki H, Oyama H. [Tsutsugamushi disease in the foothills of Mt. Fuji (author's transl)]. Kansenshogaku Zasshi. 1980 Jun; 54(6):291-8.
Score: 0.001
-
Sawaki S, Kawamura A, Tachibana T. Use of immunological studies in evaluating the clinical course of nasopharyngeal carcinoma. IARC Sci Publ (1971). 1978; (20):575-85.
Score: 0.001
-
Sawaki S, Sugano H, Hirayama T, Kawamura A, Tachibana T. Histopathological and immunological studies of nasopharyngeal carcinoma. Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi. 1975 Jun; 8(2):73-81.
Score: 0.001
-
Takada M, Murata M, Goto A, Kawamura A, Hung MH. A simple modified method of collecting blood on filter paper for anti-HTV test in seroepidemiological studies on nasopharyngeal carcinoma. Jpn J Exp Med. 1970 Oct; 40(5):391-4.
Score: 0.001